Weiss Multi Strategy Advisers LLC Axsome Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $152,180 - $327,250	-7,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $169,194 - $295,483	-7,139 Reduced 50.49%	7,000 $290,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $95,998 - $135,586	-3,127 Reduced 18.11%	14,139 $534,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $84,637 - $290,173	4,251 Added 32.66%	17,266 $569,000
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $23,542 - $34,177	465 Added 3.71%	13,015 $878,000
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $28,681 - $41,778	-513 Reduced 3.93%	12,550 $711,000
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $203,107 - $265,010	3,063 Added 30.63%	13,063 $1.06 Million
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $341,700 - $429,200	5,000 Added 100.0%	10,000 $713,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $249,350 - $493,450	5,000 New	5,000 $411,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.